1. Home
  2. ELUT vs PAVM Comparison

ELUT vs PAVM Comparison

Compare ELUT & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

N/A

Current Price

$0.79

Market Cap

42.5M

Sector

Health Care

ML Signal

N/A

Logo PAVmed Inc.

PAVM

PAVmed Inc.

N/A

Current Price

$2.76

Market Cap

41.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELUT
PAVM
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.5M
41.1M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
ELUT
PAVM
Price
$0.79
$2.76
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $36.50
AVG Volume (30 Days)
23.5K
★ 23.8K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 146.77
N/A
EPS
★ N/A
N/A
Revenue
★ $12,293,000.00
$3,000,000.00
Revenue This Year
N/A
$132.39
Revenue Next Year
N/A
$263.64
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 20.00
52 Week Low
$0.50
$0.21
52 Week High
$1.39
$28.44

Technical Indicators

Market Signals
Indicator
ELUT
PAVM
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
ELUT
PAVM

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.

Share on Social Networks: